Drugs that Don’t Help Could Hurt

Physicians continue to overprescribe antibiotics for patients with sore throats, a study finds.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, SHORELANDERSeeking relief from their acute bronchitis and sore throat symptoms, many patients pay visits to their doctors, who often prescribe antibiotics. But not all patients experiencing symptoms of bronchitis and sore throat benefit from the drugs. And according to a study published this week (October 3) in JAMA Internal Medicine, physicians who prescribe antibiotics even when they might not help may be contributing to the growing problem of drug-resistance.

“We know that antibiotic prescribing, particularly to patients who are not likely to benefit from it, increases the prevalence of antibiotic-resistant bacteria, a growing concern both here in the United States and around the world,” study coauthor Jeffrey Linder, a physician-researcher at Brigham and Women’s Hospital in Boston, said in a statement. Analyzing records from primary-care and emergency-department visits, Linder and his colleague Michael Barnett found that the national prescribing rate for adults with sore throat held steady at around 60 percent from 1997 to 2010. But only around 10 percent of adults with sore throat are infected with group A Streptococcus—the only common cause of the symptom requiring antibiotics. Meanwhile, “for acute bronchitis, the right antibiotic prescribing rate should be near zero percent, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series